Avaliação da hematúria visível

Last reviewed: 11 Apr 2025
Last updated: 25 Jun 2024

Summary

Differentials

Common

  • Hiperplasia prostática benigna (HPB)
  • Infecção do trato urinário (ITU)
  • Pielonefrite aguda
  • Câncer de bexiga
  • Câncer de próstata
  • Nefrolitíase
  • Instrumentação do trato urinário
  • Menstruação
Full details

Uncommon

  • Trauma renal
  • Trauma na bexiga
  • Trauma uretral
  • Anemia falciforme
  • Coagulopatia
  • Doença renal cística
  • Malformação arteriovenosa
  • Trombose da veia renal
  • Síndrome de Alport
  • Tuberculose extrapulmonar
  • Hematúria familiar benigna (nefropatia da membrana basal fina)
  • Glomerulonefrite pós-infecciosa
  • Glomerulonefrite membranoproliferativa
  • Glomerulonefrite rapidamente progressiva
  • Nefropatia por imunoglobulina A (IgA)
  • Lúpus eritematoso sistêmico (LES)
  • Câncer renal
  • Câncer metastático
  • Câncer uretral
  • Câncer peniano
  • Placenta percreta
  • Endometriose
  • Litíase vesical
  • Cistite por radiação
  • Medicamentos nefrotóxicos / citotóxicos
  • Anticoagulação
  • Hematúria induzida por exercício físico
  • Síndrome de dor lombar e hematúria
  • Medicação
  • Causa alimentar
Full details

Contributors

Authors

Simon Y. Kimm, MD
Simon Y. Kimm

Clinical Fellow and Instructor

Division of Urologic Oncology

Memorial Sloan-Kettering Cancer Center

New York

NY

Disclosures

SYK declares that he has no competing interests.

Jeffrey H. Reese, MD
Jeffrey H. Reese

Department of Urology

Santa Clara Valley Medical Center

San Jose

Clinical Professor of Urology

Stanford University School of Medicine

Stanford

CA

Disclosures

JHR declares that he has no competing interests.

Peer reviewers

Lynda Frassetto, MD

Associate Professor of Medicine

Division of Nephrology

University of California at San Francisco

CA

Disclosures

LF declares that she has no competing interests.

Michael Fischer, MD

Assistant Professor of Medicine

University of Illinois

Chicago College of Medicine

Department of Nephrology

Chicago

IL

Disclosures

MF declares that he has no competing interests.

Junaid Masood, MBBS, FRCS (Eng), MSc (Urol), FRCS (Urol)

Consultant Urological Surgeon

Bart's and The London NHS Trust

London

UK

Disclosures

JM declares that he has no competing interests.

Vinod Nargund, PhD, FRCS (Urol), FEBU

Consultant Urological Surgeon

Homerton University and Bartholomew's Hospitals

London

UK

Disclosures

VN declares that he has no competing interests.

References

Our in-house evidence and editorial teams collaborate with international expert contributors and peer reviewers to ensure that we provide access to the most clinically relevant information possible.

Key articles

Nielsen M, Qaseem A. Hematuria as a marker of occult urinary tract cancer: advice for high-value care from the American College of Physicians. Ann Intern Med. 2016 Apr 5;164(7):488-97.Full text  Abstract

Morey AF, Broghammer JA, Hollowell CMP, et al. Urotrauma guideline 2020: AUA guideline. J Urol. 2021 Jan;205(1):30-5.Full text  Abstract

European Association of Urology. EAU guidelines on urological trauma. Mar 2022 [internet publication].Full text

American College of Radiology. ACR appropriateness criteria: hematuria. 2019 [internet publication].Full text

Reference articles

A full list of sources referenced in this topic is available to users with access to all of BMJ Best Practice.
  • Avaliação da hematúria visível images
  • Guidelines

    • Guidelines on urological trauma
    • Urotrauma guideline
    More Guidelines
  • Patient information

    Cystitis

    Enlarged prostate: what is it?

    More Patient information
  • Videos

    Venopunção e flebotomia – Vídeo de demonstração

    More videos
  • padlock-lockedLog in or subscribe to access all of BMJ Best Practice

Use of this content is subject to our disclaimer